Natalia Szeocs

Mrs. Natalia Szeocs

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
ASApolka Kinga Szentirmay
Apolka Kinga Szentirmay
MUMárkó Unicsovics
Márkó Unicsovics
EREszter Ruff
Eszter Ruff
CBCsókay Bernadett
Csókay Bernadett
KSKatalin Sara-Popovics
Katalin Sara-Popovics
ZSZsuzsanna Szőke
Zsuzsanna Szőke
Background: Exposure to anthropogenic and/or natural (e.g., herbicides or mycotoxins) endocrine-disrupting chemicals (EDCs) has been linked to several reproductive disorders. Glyphosate (GLY), a common agricultural agent, is a potential element of the exposome that bioaccumulates and has potential endocrine and oxidative stress-related effects. However, data on its presence in the human ovarian microenvironment remain limited. Our study examined GLY levels in follicular fluid (ff) and serum and their relationships with oxidative stress markers, reproductive hormones, and stress hormones in women undergoing in vitro fertilization (IVF). Methods: 50 women undergoing controlled ovarian stimulation participated. Serum and ff samples were routinely collected during oocyte retrieval. GLY, related hormones (e.g., cortisol, estradiol-E2, anti-Müllerian hormone-AMH, and melatonin-MT), an oxidative stress marker malondialdehyde (MDA), antioxidant enzyme activities, total antioxidant capacity, and co-occurring natural pollutant mycotoxin levels were measured. Relationships between GLY levels and these mediators were assessed using correlation and regression analyses. Results: GLY was detected in both serum and ff at similar concentrations (0.038 ± 0.006 ng/mL vs. 0.045 ± 0.006 ng/mL; p = 0.414). Follicular GLY levels showed a positive association with MDA (Spearman’s r = 0.4487, p < 0.001), explaining 28.6% of the variability in follicular MDA. Serum GLY was positively associated with serum (β = 40.26, p = 0.0058) and follicular E2 (r = 0.29, p = 0.042). Serum GLY levels were negatively correlated with cortisol (β = −0.0188, p = 0.020). A slight correlation between follicular GLY and MT was observed (p = 0.03). No associations were found between GLY levels and age, body mass index, AMH, the recombinant gonadotropin dose used, antioxidant enzyme activities, follicle count, oocyte yield, or embryo viability. Conclusions: This study might be the first to demonstrate the presence of GLY of exposome in human ff, indicating that environmental exposure to GLY may reach the oocyte microenvironment. The correlation with lipid peroxidation suggests GLY could contribute to follicular oxidative stress. The associations with E2 and cortisol point to potential endocrine-disrupting effects. While no direct impact on IVF outcomes was observed, findings suggest low-level exposure to GLY could influence ovarian physiology through specific biochemical mechanisms.

26 April 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
SFSzilamér Ferenczi
Szilamér Ferenczi
IHIstván Horváth
István Horváth
NSNatalia Szeocs
Natalia Szeocs
ZGZsuzsanna Grózer
Zsuzsanna Grózer
DKDaniel Kuti
Daniel Kuti
ZSZoltan Szallasi
Zoltan Szallasi
We developed an engineered bacterium based, RNA interference mediated therapeutic method to significantly reduce the symptoms in the most frequently used animal model of inflammatory bowel disease. This transkingdom RNA interference strategy was based on the non-pathogenic E. coli MDS42 strain, which was engineered to constitutively produce invasin and histeriolysin cytolysin. These proteins enabled the bacteria first to invade the colon epithelium and then degrade in the phagosome. This allowed the delivery of a plasmid encoding shRNA targeting TNF alpha into the cytoplasm of the target cells. The expression levels of TNF alpha and other cytokines significantly decreased and the inflammatory symptoms were significantly reduced. With further safety modifications this method could serve as a safe and side-effect free alternative to biologicals targeting TNF-alpha.

4 June 2026 in Toxins
Verified
Journal Article
Open access
PDF file
SFSzilamér Ferenczi
Szilamér Ferenczi
Ildikó Bata-VidácsIldikó Bata-Vidács
Ildikó Bata-Vidács
JKJudit Kosztik
Judit Kosztik
INIstván Nagy
István Nagy
KIKatalin Inotai
Katalin Inotai
JKJózsef Kukolya
József Kukolya
Aflatoxin B1 (AFB1), a highly potent Group 1 human carcinogen produced by Aspergillus flavus (A. flavus), poses a significant contamination risk to corn silage, a threat that is further intensified by rising global temperatures. This study aimed to characterize the combined effects of temperature and co-inoculation with the lactic acid bacterium Limosilactobacillus fermentum (L. fermentum) on AFB1 production and the expression of key biosynthetic genes in A. flavus colonizing corn silage. Corn silage was incubated at 20 °C, 30 °C, and 37 °C with and without L. fermentum. Using qRT-PCR and HPLC, we found that elevated temperatures, particularly 37 °C, strongly induced the expression of the aflatoxin biosynthetic cluster, including the regulatory gene aflR and structural genes such as omtA and ordA. Co-inoculation with L. fermentum consistently reduced in the final AFB1 concentration by approximately 50–60% at all three temperatures. Molecular analysis revealed that this reduction was associated with transcriptional repression at 30 °C and 37 °C. L. fermentum consistently and markedly down-regulated the expression of aflR and all structural genes. A particularly pronounced suppression was observed for the late-pathway gene ordA at 30 °C. These findings provide molecular evidence supporting the incorporation of selected L. fermentum strains into silage inoculant formulations to mitigate the AFB1 risk under high-temperature conditions.